Contact | Print version | PDF version | Send article | RSS feed

ChemWerth, Inc. announces Wuhan Pharmaceutical Factory passes FDA inspection

02 Jul 2009 - ChemWerth Inc. reported the Wuhan Pharmaceutical Factory facility has passed an FDA overseas inspection with a two point 483 being issued. ChemWerth and Wuhan are collaborating to develop APIs for the U.S. and other regulated markets overseas. Wuhan continues to be a primary supplier of high quality Active Pharmaceutical Ingredients to the Chinese and U.S. markets.
 
According to Mr. Peter Werth, CEO, "ChemWerth has been working with the FDA in China for over 25 years and has been through approximately 100 FDA inspections. Our regulatory expertise in helping manufactures like Wuhan get approved is a real value-added benefit for our customers. We’re proud to have Wuhan as a manufacturing partner.”